Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

THE ROLE OF VITAMIN B12-DEPENDENT METABOLIC PATHWAYS IN NEURAL CREST DEVELOPMENT

Award Number: R01HD116761
ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/01/2025
PERIOD OF PERFORMANCE END DATE: 02/28/2030

Group Awards By:

View Award Description

THE ROLE OF VITAMIN B12-DEPENDENT METABOLIC PATHWAYS IN NEURAL CREST DEVELOPMENT - PROJECT SUMMARY/ABSTRACT Neural crest cells (NCCs) comprise a multipotent population of cells that migrate throughout the vertebrate embryo and differentiate into a wide variety of cell types and tissues such as the enteric, autonomic, and peripheral nervous system; tissues of the adrenal gland, thyroid gland, heart, and eye; melanocytes of the skin; and craniofacial bone and cartilage. Therefore, disruptions in NCC specification, migration, and/or differentiation can affect many aspects of embryonic development leading to an array of debilitating congenital malformations collectively called neurocristopathies. Thus, our long-term goal is to define the cellular and molecular mechanisms governing NCC development leading to new therapeutic targets. In this proposal we aim to define the syndrome combined methylmalonic acidemia and homocystinuria, cblC-type (cblC) – an inborn error of cobalamin (vitamin B12) metabolism (IECM) – as also a neurocristopathy impacting mammalian development. CblC is caused by mutation of the gene MMACHC, which encodes an enzyme essential for intracellular trafficking and metabolism of cobalamin into its active coenzyme states. Without active cobalamin, dependent metabolic pathways cannot function properly and consequently, severe neurodevelopmental defects, anemia, retinopathy, and other congenital disorders result. However, the specific contributions of each metabolic perturbation to the tissue-specific pathophysiology of cblC is largely unknown and there are no effective treatments for affected infants and children. In our preliminary studies, we discovered that Mmachc may play a role in neural crest development and thereby redefine cblC as a neurocristopathy. Therefore, this proposal aims to use novel mouse models of IECM to identify which specific cobalamin-dependent pathway, when disrupted, leads to neural crest developmental defects. We will also investigate whether modulation of the maternal environment can improve the phenotypic presentation of cblC defects in offspring. In total, these finding will shed much needed light on the pathophysiology of cblC and likely inform patient treatment.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $534,899 )
2026	2026	BAYLOR COLLEGE OF MEDICINE	1 BAYLOR PLZ	HOUSTON	TX	77030	HARRIS	USA	Child Health and Human Development Extramural Research	000	2	2/26/2026	NON-COMPETING CONTINUATION	$534,899
														Subtotal = $534,899

Issue Date FY: 2025 ( Subtotal = $534,899 )
2025	2025	BAYLOR COLLEGE OF MEDICINE	1 BAYLOR PLZ	HOUSTON	TX	77030	HARRIS	USA	Child Health and Human Development Extramural Research	000	1	5/29/2025	NEW	$534,899
														Subtotal = $534,899

Grand Total All Awards = $1,069,798

Top

All Categories

About

Search

Reports

Data Submission

Award Information

THE ROLE OF VITAMIN B12-DEPENDENT METABOLIC PATHWAYS IN NEURAL CREST DEVELOPMENT

Award Number: R01HD116761

ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/01/2025

PERIOD OF PERFORMANCE END DATE: 02/28/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer